D. Collen Research Foundation VZW
Records under this name other than patents D. Collen Research Foundation VZW holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to D. Collen Research Foundation VZW
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,357,929 | Placental growth factor as a target for the treatment of osteoporosis Formerly held Term ended Term ended Jun 27, 2023 · USPTO record | Term ended | Term ended Jun 27, 2023 | USPTO record |
| US 7,875,704 | Novel Anti-Plgf Antibody Formerly held Lapsed on the fee record Ended Jan 25, 2023 · High confidence | Lapsed on the fee record | Ended Jan 25, 2023 | High confidence |
| US 7,482,004 | Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage Formerly held Term ended Term ended Mar 21, 2022 · USPTO record | Term ended | Term ended Mar 21, 2022 | USPTO record |
| US 7,226,908 | Use of VEGF and homologues to treat neuron disorders Formerly held Lapsed on the fee record Ended Jun 5, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 5, 2019 | USPTO record |
| US 7,863,246 | Treatment of amyotrophic lateral sclerosis Formerly held Lapsed on the fee record Ended Jan 4, 2019 · USPTO record | Lapsed on the fee record | Ended Jan 4, 2019 | USPTO record |
| US 7,829,085 | Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII Formerly held Lapsed on the fee record Ended Nov 9, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 9, 2018 | USPTO record |
| US 7,105,168 | Method of improving ischemic muscle function by administering placental growth factor Lapsed on the fee record Ended Sep 12, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2018 | USPTO record |
| US 7,785,594 | Factor VIII inhibitory antibodies with reduced glycosylation Formerly held Lapsed on the fee record Ended Aug 31, 2018 · USPTO record | Lapsed on the fee record | Ended Aug 31, 2018 | USPTO record |
| US 8,784,816 | Antibodies which bind factor VIII Formerly held Lapsed on the fee record Ended Jul 22, 2018 · USPTO record | Lapsed on the fee record | Ended Jul 22, 2018 | USPTO record |
| US 7,067,313 | Ligands for use in therapeutic compositions for the treatment of hemostasis disorders Formerly held Lapsed on the fee record Ended Jun 27, 2018 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2018 | USPTO record |